Authorization of Johnson & Johnson vaccine could accelerate US immunization

by Stephen Loiaconi

Fri, February 5th 2021, 9:28 PM UTC

This Dec. 2, 2020 photo provided by Johnson & Johnson shows vials of the Janssen COVID-19 vaccine in the United States. On Thursday, Feb. 4, 2021, Johnson & Johnson has asked U.S. regulators to clear the world’s first single-dose COVID-19 vaccine, an easier-to-use option that could boost scarce supplies. (Johnson & Johnson via AP)

A sign covered with ice advertises a COVID-19 vaccination site in New York, Tuesday, Feb. 2, 2021. The site was closed due to the inclement weather.{ } (AP Photo/Seth Wenig)

FILE - In this July 30, 2013, file photo, people walk along a corridor at the headquarters of Johnson & Johnson in New Brunswick, N.J. Johnson & Johnson's long-awaited vaccine appears to protect against COVID-19 with just one shot – not as strong as some two-shot rivals but still potentially helpful for a world in dire need of more doses. (AP Photo/Mel Evans, File)

VIEW ALL PHOTOS

This Dec. 2, 2020 photo provided by Johnson & Johnson shows vials of the Janssen COVID-19 vaccine in the United States. On Thursday, Feb. 4, 2021, Johnson & Johnson has asked U.S. regulators to clear the world’s first single-dose COVID-19 vaccine, an easier-to-use option that could boost scarce supplies. (Johnson & Johnson via AP)

Loading ...